Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 1 de 1
Filter
Add filters








Year range
1.
Rev. bras. reumatol ; 48(1): 59-61, jan.-fev. 2008. ilus
Article in Portuguese | LILACS | ID: lil-482476

ABSTRACT

Os bisfosfonatos são comumente utilizados no tratamento do mieloma múltiplo e em outras neoplasias com metástases ósseas. Geralmente são bem tolerados, entretanto osteonecrose de mandíbula é um efeito adverso recentemente relatado com uso de bisfosfonatos endovenosos. Relata-se um caso de osteonecrose de mandíbula em paciente submetido ao tratamento de mieloma múltiplo com quimioterapia e pamidronato endovenoso.


Bisphosphonates are commonly used in the treatment of multiple myeloma and other bone metastatic neoplasias. They are usually well tolerated; however osteonecrosis of the jaw is a recently reported side effect seen with the use of parenteral bisphosphonates. We report a case of osteonecrosis of the jaw in a patient treated for multiple myeloma with chemotherapy and parenteral pamidronate.


Subject(s)
Humans , Female , Middle Aged , Bone Density Conservation Agents , Diphosphonates , Mandible , Mandibular Injuries , Mandibular Neoplasms , Multiple Myeloma/therapy , Osteoporosis/therapy
SELECTION OF CITATIONS
SEARCH DETAIL